14.04

2.64% -0.38

Personalis Inc (PSNL)

Overview News Price History Option Chain Financials Discussions Forecast

Personalis Inc stock is traded at $14.04, with a volume of 1.04M. It is down -2.64% in the last 24 hours and down -6.59% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Previous Close:

$14.42

Open:

$14.11

24h Volume:

1.04M

Relative Volume:

0.27

Market Cap:

$1.50B

Revenue:

$64.52M

Net Income/Loss:

$-95.55M

P/E Ratio:

-13.81

EPS:

-1.0169

Net Cash Flow:

$-84.65M

1W Performance:

-0.85%

1M Performance:

-6.59%

6M Performance:

+71.01%

1Y Performance:

+201.29%

1-Day Range:

$13.92

$14.33

1-Week Range:

$13.87

$14.81

52-Week Range:

$4.44

$16.39

Personalis Inc Stock (PSNL) Company Profile

Name

Personalis Inc

Sector

Healthcare (1080)

Industry

Diagnostics & Research (50)

Phone

650-752-1300

Address

6600 DUMBARTON CIRCLE, FREMONT, CA

Employee

260

Twitter

@PersonalisInc

Next Earnings Date

2026-08-04

Latest SEC Filings

PSNL's Discussions on Twitter

Compare PSNL vs TMO, DHR, NTRA, IDXX, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PSNL Personalis Inc	14.04	1.52B	64.52M	-95.55M	-84.65M	-1.0169
TMO Thermo Fisher Scientific Inc	588.29	222.96B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	202.45	144.67B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	309.93	45.54B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	550.96	44.95B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.53	41.87B	7.23B	1.41B	1.09B	4.979

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
May-15-25	Initiated	Guggenheim	Buy
Mar-17-25	Initiated	Craig Hallum	Buy
Feb-06-23	Upgrade	Needham	Hold → Buy
Jan-07-22	Upgrade	BofA Securities	Neutral → Buy
Nov-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-03-21	Downgrade	Needham	Buy → Hold
Oct-15-21	Resumed	Cowen	Outperform
Sep-20-21	Reiterated	Needham	Buy
May-06-21	Upgrade	Oppenheimer	Perform → Outperform
Jan-28-21	Initiated	Truist	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Nov-12-20	Reiterated	Needham	Buy
Nov-06-20	Downgrade	Oppenheimer	Outperform → Perform
Oct-19-20	Initiated	Citigroup	Buy
Oct-08-20	Initiated	BTIG Research	Buy
Aug-27-20	Initiated	H.C. Wainwright	Buy
Aug-18-20	Initiated	Needham	Buy
Sep-26-19	Upgrade	BofA/Merrill	Neutral → Buy
Jul-15-19	Initiated	BofA/Merrill	Neutral
Jul-15-19	Initiated	Cowen	Outperform
Jul-15-19	Initiated	Morgan Stanley	Overweight
Jul-15-19	Initiated	Oppenheimer	Outperform

View All

Personalis Inc Stock (PSNL) Latest News

02:31 AM

What Personalis (PSNL)'s Rising Revenue But Deepening Losses Means For Shareholders - simplywall.st

02:31 AM

Aug 14, 2026

Ameriprise Financial (PSNL) discloses 5.8% ownership stake in Personalis common stock - Stock Titan

Aug 14, 2026

Deep Track Capital (PSNL) reports 4,000,000 Personalis shares, now under 5% ownership - Stock Titan

Aug 14, 2026

Sei Investments Co. Buys 83,040 Shares of Personalis, Inc. $PSNL - MarketBeat

Aug 14, 2026

Aug 12, 2026